Skip to main content
OpenTrials
Completed

NCT Number: NCT00323648

Does it Make Sense to Give Postoperative Antibiotics to Patients With an Uncomplicated Acute Cholecystitis

Each patient is preoperatively treated once profylactic with intraveneous antibiotics. Postoperatively, one group will be treated with intraveneous antibiotics during 5 days. The other group will receive no antibiotics.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

University Hospital Ghent, Ghent, Belgium

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Uncomplicated acute cholecystitis < 5 days(confirmed by echography and blood sample)
  • > 18 years old

Exclusion criteria

-

Treatment and study plan

Whether or not giving postoperatively antibiotics to patients with an uncomplicated acute cholecystitis

Drug

Whether or not giving postoperatively antibiotics to patients with an uncomplicated acute cholecystitis.

Primary outcomes

  1. Postoperative complications (abces, infection of the wound)

    Time frame: day 2, day of discharge and dag 21

Secondary outcomes

  1. Duration of hospitalisation

    Time frame: Day O to day of discharge

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Registry information

Important dates

Study start
2006
Primary completion
2010
Study completion
2013
First posted
May 9, 2006
Registry last updated
Dec 5, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.